← Back to Search

Vasodilator

Oral Minoxidil for Hair Loss in Childhood Cancer Survivors

Q: Does this trial offer me the opportunity to take part?

To be accepted as a participant in this study, one must suffer from <a href="https://www.withpower.com/clinical-trials/alopecia">alopecia</a> and fit the age criteria of 6-18. This medical trial is searching for 60 applicants in total.

Q: Has Oral Minoxidil obtained the stamp of approval from the FDA?

Based on our evaluation, the safety of Oral Minoxidil scored a 2. This is because this Phase 2 trial has limited data for both efficacy and safety profiles.

Q: Is this research endeavor accepting new participants?

Affirmative, the information hosted on clinicaltrials.gov indicates that this research trial has started seeking out applicants since March 10th and is still actively recruiting 60 people from a single location.

Q: Does the trial accept participants older than 65 years of age?

The requirements for inclusion in this medical trial state that participants should be aged 6 to 18. Additionally, there are 14 clinical trials specifically reserved for young people and 61 dedicated studies targeting those over the age of 65.

Q: What is the optimal number of participants for this experiment?

Yes, the data on clinicaltrials.gov establishes that this clinical trial is still accepting applicants. This study was first made public on March 10th 2023 and has since been amended as recently as March 10th 2023. A total of 60 individuals are required to be enrolled at a single site for the experiment's completion.

Phase 2

Recruiting

Led By Alina Markova, MD

Research Sponsored by Memorial Sloan Kettering Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

They must have completed either systemic or radiation therapy (cytotoxic chemotherapy and external beam radiation therapy) for their cancer at least 1 year prior to study entry.

They must be between 6-18 years old at the time of enrollment.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at 8 months

Awards & highlights

Study Summary

This trial will test if a drug can improve hair loss caused by cancer treatment in kids and young adults. Safety, dosing & quality of life will be monitored.

Who is the study for?

This trial is for children and young adults aged 6-18 who are cancer survivors with hair loss related to past chemotherapy or radiation. They must have finished their cancer treatment at least a year ago, not be on other alopecia treatments, and can't have low blood pressure or certain heart conditions.Check my eligibility

What is being tested?

The study is testing if oral Minoxidil helps improve hair growth in young cancer survivors compared to a placebo. It will also assess the drug's safety, adherence to dosing schedules by participants, and its impact on their quality of life.See study design

What are the potential side effects?

Possible side effects of oral Minoxidil may include changes in blood pressure, heart rate alterations, scalp irritation, unwanted facial/body hair growth. Side effects vary from person to person.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I finished my cancer treatment (chemotherapy or radiation) over a year ago.

Select...

I am between 6 and 18 years old.

Select...

I was diagnosed with cancer before turning 17.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at 8 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at 8 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and at 8 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

change in the target area (1/3 of the distance midline from glabella to occiput from the front toward the back) hair density

Side effects data

From 2011 Phase 3 trial • 404 Patients • NCT01226459

Weight Increased

Nasopharyngitis

Upper Respiratory Tract Infection

Headache

Hypertension

Sinusitis

Asthenia

Back Pain

100%

80%

60%

40%

20%

Study treatment Arm

Vehicle Foam

Minoxidil Foam

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Oral MinoxidilExperimental Treatment1 Intervention

Patients receive oral minoxidil at a dose of 0.01 (<40kg) and 0.02 (≥40kg) mg/kg/day for 8 months

Group II: Placebo followed by oral MinoxidilActive Control2 Interventions

Patient receive placebo for 4 months followed by oral minoxidil for 4 months

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor

1,936 Previous Clinical Trials

588,838 Total Patients Enrolled

2 Trials studying Alopecia

576 Patients Enrolled for Alopecia

Alina Markova, MDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center

7 Previous Clinical Trials

787 Total Patients Enrolled

1 Trials studying Alopecia

546 Patients Enrolled for Alopecia

Mario Lacouture, MDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center

9 Previous Clinical Trials

2,047 Total Patients Enrolled

1 Trials studying Alopecia

546 Patients Enrolled for Alopecia

Media Library

Oral Minoxidil (Vasodilator) Clinical Trial Eligibility Overview. Trial Name: NCT05778825 — Phase 2

Alopecia Research Study Groups: Oral Minoxidil, Placebo followed by oral Minoxidil

Alopecia Clinical Trial 2023: Oral Minoxidil Highlights & Side Effects. Trial Name: NCT05778825 — Phase 2

Oral Minoxidil (Vasodilator) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05778825 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this trial offer me the opportunity to take part?

"To be accepted as a participant in this study, one must suffer from alopecia and fit the age criteria of 6-18. This medical trial is searching for 60 applicants in total."

Answered by AI

Has Oral Minoxidil obtained the stamp of approval from the FDA?

"Based on our evaluation, the safety of Oral Minoxidil scored a 2. This is because this Phase 2 trial has limited data for both efficacy and safety profiles."

Answered by AI

Is this research endeavor accepting new participants?

"Affirmative, the information hosted on clinicaltrials.gov indicates that this research trial has started seeking out applicants since March 10th and is still actively recruiting 60 people from a single location."

Answered by AI

Does the trial accept participants older than 65 years of age?

"The requirements for inclusion in this medical trial state that participants should be aged 6 to 18. Additionally, there are 14 clinical trials specifically reserved for young people and 61 dedicated studies targeting those over the age of 65."

Answered by AI

What is the optimal number of participants for this experiment?

"Yes, the data on clinicaltrials.gov establishes that this clinical trial is still accepting applicants. This study was first made public on March 10th 2023 and has since been amended as recently as March 10th 2023. A total of 60 individuals are required to be enrolled at a single site for the experiment's completion."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors

2023. "A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05778825.

All > Androgenetic Alopecia > Alopecia Areata